Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (UC4 DK108132)
EC | Horizon 2020 Framework Programme (866074)
SNSF: Swiss national science foundation
Article History
Received: 12 June 2022
Accepted: 5 July 2023
First Online: 31 August 2023
Competing interests
: B.B. is a founder and shareholder of Navignostics, a precision oncology spin-off from the University of Zurich, based on multiplexed imaging. All other authors declare no competing interests.